Clinical integration of germline findings from a tumor testing precision medicine program
Abstract Background Integrating germline genetic testing (GGT) recommendations from tumor testing into hereditary cancer clinics and precision oncology trials presents challenges that require multidisciplinary expertise and infrastructure. While there have been advancements in standardizing molecula...
Saved in:
Main Authors: | Maria Carolina Sanabria-Salas, Nina C. Anggala, Brittany Gillies, Kirsten M. Farncombe, Renee Hofstedter, Larissa Peck, Helia Purnaghshband, Laura Redondo, Emily Thain, Wei Xu, Peter Sabatini, Philippe L. Bedard, Raymond H. Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-025-13487-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients
by: Esra ARSLAN ATES, et al.
Published: (2022-06-01) -
Genetics of Inflammatory Bowel Disease: Current Understanding and Future Directions
by: P. K. Chandra Sekar, et al.
Published: (2024-12-01) -
Melasma management: Unveiling recent breakthroughs through literature analysis
by: Darshan Kumar R, et al.
Published: (2025-03-01) -
Investigating knowledge and attitudes toward genetic testing and counseling among palestinians
by: Mustafa Ghanim, et al.
Published: (2025-02-01) -
Heterogeneity of Genetic Landscapes in Salivary Gland Tumors and Their Critical Roles in Current Management
by: Anam YOUSAF, et al.
Published: (2022-06-01)